Institute of Science Tokyo · Graduate School of Medical and Dental Sciences

Research keywords転移性大腸癌・トリフルリジン・チピラシル・レゴラフェニブ効果予測・RAS/BRAF変異・抗EGFR療法・消化器癌薬物療法・免疫関連大腸炎・包括的ゲノムプロファイル・Bacteroides fragilis・薬理ゲノミクス

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Takeshi Yamada;Takeshi Nagasaka;Nobuhisa Matsuhashi;Takao Takahashi;Keiji Hirata;Yuki Nakamura;Kiichi Sugimoto;Keiji Koda;Kazuhiro Hiramatsu;Hiroshi Matsuoka;Hidekazu Kuramochi;Akihisa Matsuda;Hideyuki Ishida;Kozo Kataoka;Hajime Yokomizo;Yoshinori Kagawa;Mitsukuni Suenaga;Hiroshi Yoshida. Clinical Impact of Baseline ctDNA RAS/BRAF Mutations on Conversion Surgery and Outcomes in First-Line Anti-EGFR Therapy for Advanced Colorectal Cancer Cancers. 2026.05; 18 (11): 1688. ( DOI )2026
• M. Suenaga , T. Mashima , N. Kawata , S. Dan , H. Seimiya , K. Yamaguchi. Preclinical identification and clinical validation of dynamic biomarkers for trifluridine/tipiracil with or without bevacizumab in metastatic colorectal cancer ESMO Gastrointestinal Oncology. 2026.06; 12 100323. ( PubMed , DOI )2026
• Morikawa R, Fujii T, Tamura A, Kawamoto A, Hibiya S, Takenaka K, Shimizu H, Kano Y, Suenaga M, Hamamoto Y, Ohtsuka K, Okamoto R. Diagnostic Performance of Fecal Biomarkers and Their Correlation with Endoscopic Severity in Immune Checkpoint Inhibitor- Related Colitis. Digestion. 2025.12; 1-14. ( PubMed , DOI )2025
• 鳥羽 智美, 加納 嘉人, 永塚 杏, 藤原 俊, 末永 光邦, 上林 秀考, 大西 威一郎, 浜本 康夫. 大腸癌切除後8年を経て巨大孤立性肝転移を呈し、肝内胆管癌と鑑別を要した1例 日本内科学会関東地方会. 2025.10; 708回 44. ( 医中誌 )2025

• Official profile